Vital Signs Monitors is a special device that is used for keeping track of the vital signs of patient鈥檚 health. This patient monitoring equipment is generally used in different hospital departments to monitor patients in their beds. The equipment measures blood pressure, etc. temperature, respiration rate and other data.
The global ICU Vital Signs Monitor market was valued at US$ 4361.5 million in 2023 and is anticipated to reach US$ 5739.5 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The Vital Signs Monitor market is primarily driven by the increasing need for continuous patient monitoring in healthcare settings. Vital signs monitors offer real-time tracking of essential parameters like heart rate, blood pressure, and oxygen saturation, enhancing patient safety and enabling timely interventions. The growing demand for remote patient monitoring, especially in home healthcare and telemedicine, contributes to market growth. Moreover, the advancements in monitoring technology, such as wireless connectivity and user-friendly interfaces, further propel adoption. However, challenges include ensuring accuracy and reliability of measurements, particularly in diverse patient populations, and addressing potential data overload for healthcare professionals. Striking a balance between device portability and durability, as well as integrating vital signs data into electronic health records, are ongoing concerns. The market's success relies on continuous innovation in monitor design, seamless interoperability with healthcare systems, and collaborations between medical device manufacturers and healthcare providers to offer comprehensive and user-friendly vital signs monitoring solutions while navigating the evolving challenges associated with patient monitoring accuracy and data management.
This report aims to provide a comprehensive presentation of the global market for ICU Vital Signs Monitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICU Vital Signs Monitor.
Report Scope
The ICU Vital Signs Monitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICU Vital Signs Monitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICU Vital Signs Monitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Philips Healthcare
GE Healthcare
Nihon Kohden
Dragerwerk
Mindray
OSI (Spacelabs)
Hill-Rom (Welch Allyn)
Edan
Smiths Medical
Biolight
Schiller
Creative Medical
CAS Medical Systems
Segment by Type
High-acuity Monitors
Mid-acuity Monitors
Low-acuity Monitors
Segment by Application
Adult ICU
Neonatal ICU
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ICU Vital Signs Monitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ICU Vital Signs Monitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 ICU Vital Signs Monitor 麻豆原创 Overview
1.1 Product Overview and Scope of ICU Vital Signs Monitor
1.2 ICU Vital Signs Monitor Segment by Type
1.2.1 Global ICU Vital Signs Monitor 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 High-acuity Monitors
1.2.3 Mid-acuity Monitors
1.2.4 Low-acuity Monitors
1.3 ICU Vital Signs Monitor Segment by Application
1.3.1 Global ICU Vital Signs Monitor 麻豆原创 Value by Application: (2024-2030)
1.3.2 Adult ICU
1.3.3 Neonatal ICU
1.4 Global ICU Vital Signs Monitor 麻豆原创 Size Estimates and Forecasts
1.4.1 Global ICU Vital Signs Monitor Revenue 2019-2030
1.4.2 Global ICU Vital Signs Monitor Sales 2019-2030
1.4.3 Global ICU Vital Signs Monitor 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ICU Vital Signs Monitor 麻豆原创 Competition by Manufacturers
2.1 Global ICU Vital Signs Monitor Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global ICU Vital Signs Monitor Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global ICU Vital Signs Monitor Average Price by Manufacturers (2019-2024)
2.4 Global ICU Vital Signs Monitor Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ICU Vital Signs Monitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ICU Vital Signs Monitor, Product Type & Application
2.7 ICU Vital Signs Monitor 麻豆原创 Competitive Situation and Trends
2.7.1 ICU Vital Signs Monitor 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest ICU Vital Signs Monitor Players 麻豆原创 Share by Revenue
2.7.3 Global ICU Vital Signs Monitor 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICU Vital Signs Monitor Retrospective 麻豆原创 Scenario by Region
3.1 Global ICU Vital Signs Monitor 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ICU Vital Signs Monitor Global ICU Vital Signs Monitor Sales by Region: 2019-2030
3.2.1 Global ICU Vital Signs Monitor Sales by Region: 2019-2024
3.2.2 Global ICU Vital Signs Monitor Sales by Region: 2025-2030
3.3 Global ICU Vital Signs Monitor Global ICU Vital Signs Monitor Revenue by Region: 2019-2030
3.3.1 Global ICU Vital Signs Monitor Revenue by Region: 2019-2024
3.3.2 Global ICU Vital Signs Monitor Revenue by Region: 2025-2030
3.4 North America ICU Vital Signs Monitor 麻豆原创 Facts & Figures by Country
3.4.1 North America ICU Vital Signs Monitor 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ICU Vital Signs Monitor Sales by Country (2019-2030)
3.4.3 North America ICU Vital Signs Monitor Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe ICU Vital Signs Monitor 麻豆原创 Facts & Figures by Country
3.5.1 Europe ICU Vital Signs Monitor 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ICU Vital Signs Monitor Sales by Country (2019-2030)
3.5.3 Europe ICU Vital Signs Monitor Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ICU Vital Signs Monitor 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific ICU Vital Signs Monitor 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ICU Vital Signs Monitor Sales by Country (2019-2030)
3.6.3 Asia Pacific ICU Vital Signs Monitor Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America ICU Vital Signs Monitor 麻豆原创 Facts & Figures by Country
3.7.1 Latin America ICU Vital Signs Monitor 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ICU Vital Signs Monitor Sales by Country (2019-2030)
3.7.3 Latin America ICU Vital Signs Monitor Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ICU Vital Signs Monitor 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa ICU Vital Signs Monitor 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ICU Vital Signs Monitor Sales by Country (2019-2030)
3.8.3 Middle East and Africa ICU Vital Signs Monitor Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ICU Vital Signs Monitor Sales by Type (2019-2030)
4.1.1 Global ICU Vital Signs Monitor Sales by Type (2019-2024)
4.1.2 Global ICU Vital Signs Monitor Sales by Type (2025-2030)
4.1.3 Global ICU Vital Signs Monitor Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global ICU Vital Signs Monitor Revenue by Type (2019-2030)
4.2.1 Global ICU Vital Signs Monitor Revenue by Type (2019-2024)
4.2.2 Global ICU Vital Signs Monitor Revenue by Type (2025-2030)
4.2.3 Global ICU Vital Signs Monitor Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global ICU Vital Signs Monitor Price by Type (2019-2030)
5 Segment by Application
5.1 Global ICU Vital Signs Monitor Sales by Application (2019-2030)
5.1.1 Global ICU Vital Signs Monitor Sales by Application (2019-2024)
5.1.2 Global ICU Vital Signs Monitor Sales by Application (2025-2030)
5.1.3 Global ICU Vital Signs Monitor Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global ICU Vital Signs Monitor Revenue by Application (2019-2030)
5.2.1 Global ICU Vital Signs Monitor Revenue by Application (2019-2024)
5.2.2 Global ICU Vital Signs Monitor Revenue by Application (2025-2030)
5.2.3 Global ICU Vital Signs Monitor Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global ICU Vital Signs Monitor Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Philips Healthcare
6.1.1 Philips Healthcare Corporation Information
6.1.2 Philips Healthcare Description and Business Overview
6.1.3 Philips Healthcare ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Philips Healthcare ICU Vital Signs Monitor Product Portfolio
6.1.5 Philips Healthcare Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare ICU Vital Signs Monitor Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Nihon Kohden
6.3.1 Nihon Kohden Corporation Information
6.3.2 Nihon Kohden Description and Business Overview
6.3.3 Nihon Kohden ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nihon Kohden ICU Vital Signs Monitor Product Portfolio
6.3.5 Nihon Kohden Recent Developments/Updates
6.4 Dragerwerk
6.4.1 Dragerwerk Corporation Information
6.4.2 Dragerwerk Description and Business Overview
6.4.3 Dragerwerk ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dragerwerk ICU Vital Signs Monitor Product Portfolio
6.4.5 Dragerwerk Recent Developments/Updates
6.5 Mindray
6.5.1 Mindray Corporation Information
6.5.2 Mindray Description and Business Overview
6.5.3 Mindray ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mindray ICU Vital Signs Monitor Product Portfolio
6.5.5 Mindray Recent Developments/Updates
6.6 OSI (Spacelabs)
6.6.1 OSI (Spacelabs) Corporation Information
6.6.2 OSI (Spacelabs) Description and Business Overview
6.6.3 OSI (Spacelabs) ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.6.4 OSI (Spacelabs) ICU Vital Signs Monitor Product Portfolio
6.6.5 OSI (Spacelabs) Recent Developments/Updates
6.7 Hill-Rom (Welch Allyn)
6.6.1 Hill-Rom (Welch Allyn) Corporation Information
6.6.2 Hill-Rom (Welch Allyn) Description and Business Overview
6.6.3 Hill-Rom (Welch Allyn) ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hill-Rom (Welch Allyn) ICU Vital Signs Monitor Product Portfolio
6.7.5 Hill-Rom (Welch Allyn) Recent Developments/Updates
6.8 Edan
6.8.1 Edan Corporation Information
6.8.2 Edan Description and Business Overview
6.8.3 Edan ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Edan ICU Vital Signs Monitor Product Portfolio
6.8.5 Edan Recent Developments/Updates
6.9 Smiths Medical
6.9.1 Smiths Medical Corporation Information
6.9.2 Smiths Medical Description and Business Overview
6.9.3 Smiths Medical ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Smiths Medical ICU Vital Signs Monitor Product Portfolio
6.9.5 Smiths Medical Recent Developments/Updates
6.10 Biolight
6.10.1 Biolight Corporation Information
6.10.2 Biolight Description and Business Overview
6.10.3 Biolight ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biolight ICU Vital Signs Monitor Product Portfolio
6.10.5 Biolight Recent Developments/Updates
6.11 Schiller
6.11.1 Schiller Corporation Information
6.11.2 Schiller ICU Vital Signs Monitor Description and Business Overview
6.11.3 Schiller ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Schiller ICU Vital Signs Monitor Product Portfolio
6.11.5 Schiller Recent Developments/Updates
6.12 Creative Medical
6.12.1 Creative Medical Corporation Information
6.12.2 Creative Medical ICU Vital Signs Monitor Description and Business Overview
6.12.3 Creative Medical ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Creative Medical ICU Vital Signs Monitor Product Portfolio
6.12.5 Creative Medical Recent Developments/Updates
6.13 CAS Medical Systems
6.13.1 CAS Medical Systems Corporation Information
6.13.2 CAS Medical Systems ICU Vital Signs Monitor Description and Business Overview
6.13.3 CAS Medical Systems ICU Vital Signs Monitor Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAS Medical Systems ICU Vital Signs Monitor Product Portfolio
6.13.5 CAS Medical Systems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ICU Vital Signs Monitor Industry Chain Analysis
7.2 ICU Vital Signs Monitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ICU Vital Signs Monitor Production Mode & Process
7.4 ICU Vital Signs Monitor Sales and 麻豆原创ing
7.4.1 ICU Vital Signs Monitor Sales Channels
7.4.2 ICU Vital Signs Monitor Distributors
7.5 ICU Vital Signs Monitor Customers
8 ICU Vital Signs Monitor 麻豆原创 Dynamics
8.1 ICU Vital Signs Monitor Industry Trends
8.2 ICU Vital Signs Monitor 麻豆原创 Drivers
8.3 ICU Vital Signs Monitor 麻豆原创 Challenges
8.4 ICU Vital Signs Monitor 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Philips Healthcare
GE Healthcare
Nihon Kohden
Dragerwerk
Mindray
OSI (Spacelabs)
Hill-Rom (Welch Allyn)
Edan
Smiths Medical
Biolight
Schiller
Creative Medical
CAS Medical Systems
听
听
*If Applicable.
